Results
Alembic Pharmaceuticals Q2 FY27 Revenue Jumps 36% YoY
Alembic Pharmaceuticals reported strong Q2 FY27 results with consolidated revenue surging 36% YoY to ₹2,603 crore and PAT up 81%.
The company raised its full-year revenue growth guidance to 20-25% fro
